Pay in 4 interest-free payments of $25.25 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
logKpot(NO3/HPO4):-4
A high percentage of the well-separated single nucleus can be obtained in about 30 min
Human CD16 is a low affinity receptor for complexed IgG and occurs in two distinct forms
Inhibition of V-ATPase activity with bafilomycin A1 led to the exacerbation of NLRP3 inflammasome activation in human monocytes in response to LPS
It is also very difficult to lyse cells in the tissue for total protein extraction
Bortezomib 1380723-44-3 logKpot(NO3/HPO4):-4Bortezomib (PS 341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0. 6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF B. Bortezomib is the first proteasome inhibitor anticancer agent. Anti cancer activity.